Price:
Rs. 6,890.00
Sample Type: EDTA BLOOD
Fasting Not Required
Notes: J0003
Frequently Asked Questions (FAQ's):
What does the JAK2 Exon 12 Mutation Detection test include?
This test analyzes the JAK2 gene segment to detect pathogenic mutations linked to myeloproliferative disorders.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses highly sensitive molecular PCR technology to identify mutations in the JAK2 exon 12 gene region.
Who should take this test?
Patients with unexplained elevated hemoglobin, high hematocrit, increased red cell mass, or suspected Polycythemia Vera should undergo this test.
What sample is required for the test?
The test requires EDTA whole blood collected under sterile conditions and processed at Metropolis Healthcare.
Is fasting needed before giving the blood sample?
No fasting is required; the sample can be given at any time.
How long does it take to receive results?
Test results are typically available within 5–7 business days at Metropolis Healthcare.
Why is this test important?
It helps confirm the diagnosis of myeloproliferative neoplasms and guides treatment decisions such as cytoreductive therapy or targeted medications.
Does Metropolis Healthcare offer additional related tests?
Yes, Metropolis Healthcare provides a comprehensive range of hematology and molecular panels, including JAK2 V617F and MPL/CALR mutation analysis